cyclohexyl-{4-[5-(3,4-dichlorophenyl)-2-piperidin-4-yl-3-propyl-3h-imidazol-4-yl]-pyrimidin-2-yl}amine

Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin–4-Yl–3–Propyl–3H-Imidazol–4-Yl]–Pyrimidin–2-Yl}Amine is a synthetic small molecule belonging to the phenylimidazole class of organic compounds[1][2]. It has a molecular formula of C27H34Cl2N6 and a molecular weight of approximately 513.5 g/mol[1][2][3]. The compound is listed in chemical and pharmaceutical databases as an experimental molecule with no current approved medical indications or clinical trial activity[1][2]. Its mechanism of action and pharmacological targets are not described in public drug databases. It is referenced as part of kinase inhibitor screening panels (notably for mitogen‐activated protein kinases such as MAPK10 and MAPK14), but there is no evidence it has been developed for any therapeutic use or reached clinical trials[1][2][10].

Other names

N-cyclohexyl-4-[5-(3,4-dichlorophenyl)-2-piperidin-4-yl]-3-propylimidazol-4-yl-pyrimidinaminN-cyclohexyl 4-[5-(3,4-dichlorophenyl)-2-(piperidin 4 yl)-1-propylimidzol 5 yl] pyrimidin 2 amine